Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

ARRIVENT BIOPHARMA INC (AVBP)

116 + Investors. Track Smart Money conviction in AVBP. See who's accumulating, reducing, or initiating positions.

Fetching live quote...
Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↑ +15
Streak
3Q ▲
Buyers last Q
59%

Smart Money Signals — AVBP

Based on 116 hedge funds · latest filing: 2025 Q4 · updated quarterly

📈

Buying streak — 3 quarters in a row

last 6Q
For 3 consecutive quarters, more hedge funds added AVBP than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.
🏔️

At the ownership peak (100% of max)

100% of all-time peak
116 hedge funds hold AVBP right now — the highest count in 3.0 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.
🚀

Fast accumulation — +47% more funds vs a year ago

fund count last 6Q
+37 new funds entered over the past year (+47% YoY). That's a rapid rush of institutional money. Fast accumulation often signals a major thesis — but it also means the stock could fall quickly if that thesis breaks.
🟡

Slight buying edge — 59% buying

68 buying47 selling
Last quarter: 68 funds bought or added vs 47 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.
📈

More new buyers each quarter (+11 vs last Q)

new funds entering per quarter
Funds opening a new AVBP position: 15 → 26 → 18 → 29. A growing influx of new institutional buyers means the asset is still gathering momentum — the consensus hasn't fully saturated yet.
🔄

Mostly new holders — 33% entered in last year

3% conviction (2yr+) 64% medium 33% new
Only 4 funds (3%) have held >2 years. The majority of current holders are relatively new to the position. New holders tend to sell faster when prices drop — a shallow conviction base that could amplify any sell-off.
📈

Growing discovery — still being found

21 → 15 → 26 → 18 → 29 new funds/Q
New funds entering each quarter: 15 → 26 → 18 → 29. A growing number of institutions are discovering AVBP each quarter. The narrative is still spreading — leaving room for ongoing capital accumulation.
📊

Mixed cohorts — 6% veterans, 47% new entrants

6% veterans 47% 1-2yr 47% new
Of 116 current holders: 7 (6%) held 2+ years, 55 held 1–2 years, 54 (47%) entered in the past year. Balanced distribution — some institutional memory, some recent momentum buyers.

Strong quality — 24% AUM from major funds

24% from top-100 AUM funds
27 of 116 holders rank in the top 100 by AUM, accounting for 24% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.
4.4
out of 10
Moderate Exit Risk
Exit risk score 4.4/10 — some crowding factors present, but no critical concentration. Watch ownership trend over the next 1–2 quarters for direction.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Hedge Fund Ownership: AVBP

How many hedge funds hold AVBP — quarterly history vs. share price
Quarterly hedge fund ownership of AVBP vs. share price

Market Analysis: AVBP

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: AVBP

-- --
Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

26 top-rated funds 2 high-conviction
Consensus
6.2
/ 10
breadth
×
Elite
2.5
/ 10
conviction
Hedge Fund Positioning: AVBP
2026 Q1 Stats Unlock in 22 days 116 + Investors

Track Smart Money conviction in AVBP. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2025 Q4) Prior (2025 Q3) Change
Funds Holding 116 103 12.62%
13F Shares 40M 39M 4.61%
Total Value $817M $714M 14.42%
New Positions 29 20 +9
Increased Positions 39 43 -4
Closed Positions 16 11 +5
Reduced Positions 33 19 +14
Total Calls 1 1 -
Total Puts 0 2 -100.0%
PUT/CALL Ratio 0.0 2.0 Bullish

Statistics: AVBP

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q1)

116 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in AVBP. Verified SEC 13F-HR filings.

Top 12 institutional holders of AVBP — 2025 Q4 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 MOODY ALDRICH PARTNERS LLC 0.23% 56,088 $1.3M
2 E Fund Management Co., Ltd. 0.06% 93,953 $2.2M
3 PROFUND ADVISORS LLC 0.01% 16,813 $388K
4 SG Americas Securities, LLC 0.00% 48,716 $1K
5 Versant Capital Management, Inc 0.00% 423 $10K
6 GAMMA Investing LLC 0.00% 359 $8K
7 GF FUND MANAGEMENT CO. LTD. 0.00% 919 $21K
8 Farther Finance Advisors, LLC 0.00% 671 $16K
9 SIGNATUREFD, LLC 0.00% 368 $8K
10 Sterling Capital Management LLC 0.00% 209 $5K
11 True Wealth Design, LLC 0.00% 6
12 Root Financial Partners, LLC 0.00% 18
Investor Ownership
History
% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — ARRIVENT BIOPHARMA INC (AVBP)

What does the Smart Money Trend signal show for AVBP?

Buying streak — 3 quarters in a row: For 3 consecutive quarters, more hedge funds added AVBP than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for AVBP?

Slight buying edge — 59% buying: Last quarter: 68 funds bought or added vs 47 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.

What is the fund quality score for AVBP holders?

Strong quality — 24% AUM from major funds: 27 of 116 holders rank in the top 100 by AUM, accounting for 24% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.

How long have hedge funds held AVBP?

Mostly new holders — 33% entered in last year: Only 4 funds (3%) have held >2 years. The majority of current holders are relatively new to the position. New holders tend to sell faster when prices drop — a shallow conviction base that could amplify any sell-off.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.